Gene Salkind - 17 Jan 2025 Form 4 Insider Report for UPEXI, INC. (UPXI)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
25 Apr 2025, 16:01:17 UTC
Prior SEC filing
02 Jan 2025
Next SEC filing
06 Mar 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Gene Salkind

Key filing fact

Gene Salkind filed Form 4 for UPEXI, INC. (UPXI) on 25 Apr 2025.

Key facts

  • This page summarizes Gene Salkind's Form 4 filing for UPEXI, INC. (UPXI).
  • 3 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 25 Apr 2025, 16:01.

Change

  • Previous filing in this sequence was filed on 02 Jan 2025.
  • Current net transaction value: +$550,002.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

UPXI transaction

Common Stock

Purchase

Transaction value
$550,002
Shares
+241,229
Change %
+195%
Price
$2.28
Shares after
365,127
Date
17 Apr 2025
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

UPXI transaction Derivative

Options to buy common stock

Award

Transaction value
$0
Shares
+25,000
Change %
Price
$0.000000
Shares after
25,000
Date
17 Jan 2025
Ownership
Direct
Underlying class
Common
Underlying amount
25,000
Exercise price
$3.46
UPXI transaction Derivative

Options to buy common stock

Award

Transaction value
$0
Shares
+35,000
Change %
Price
$0.000000
Shares after
35,000
Date
17 Apr 2025
Ownership
Direct
Underlying class
Common
Underlying amount
35,000
Exercise price
$2.28
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The Reporting Person purchased these shares in a PIPE offering conducted by the Issuer. The shares are restricted securities subject to transfer restrictions under Rule 144 of the Securities Act until such time that they are registered pursuant to a registration statement or become eligible for resale otherwise.

Footnote F2

100% of the options vest on April 17, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .